Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ABEONA THERAPEUTICS INC.ABEO · Entity 5808 | Director | September 01, 2026 | September 01, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ABEONA THERAPEUTICS INC.
Report date September 01, 2026 · Filed September 01, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 62,065 |
Reported balance
After 2026-09-01 transaction · row 1
1 source rowRow 1 · 2026-09-01 · Sale · Disposed 15,000 · Balance 62,065 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.80 to $5.9250 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.80 to $5.9250 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 01, 2026 Filed Sep 1, 2026 21:48 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | SaleCommon Stock | 15,000 | $5.86 | $87,966.00 |
DisclosureSEC source: 0001493152-26-041068 · ownership.xml · nonDerivative · entry 1 Alvino Mark · CIK 0001356828 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,065 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.80 to $5.9250 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| May 26, 2026 Filed May 26, 2026 20:30 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | GiftCommon Stock | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-025258 · ownership.xml · nonDerivative · entry 1 Alvino Mark · CIK 0001356828 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,065 Read SEC document |
| May 22, 2026 Filed May 22, 2026 21:24 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | SaleCommon Stock | 6,500 | $5.46 | $35,462.70 |
DisclosureSEC source: 0001493152-26-025085 · ownership.xml · nonDerivative · entry 1 Alvino Mark · CIK 0001356828 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,565 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.44 to $5.47 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| February 02, 2026 Filed Feb 2, 2026 21:30 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | SaleCommon Stock | 2,000 | $5.09 | $10,181.20 |
DisclosureSEC source: 0001493152-26-004759 · ownership.xml · nonDerivative · entry 1 Alvino Mark · CIK 0001356828 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,065 F1 · kind: The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.09 to $5.12 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| January 26, 2026 Filed Jan 27, 2026 21:30 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | GrantCommon Stock | 37,313 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-003804 · ownership.xml · nonDerivative · entry 1 Alvino Mark · CIK 0001356828 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,065 F1 · shares: All of the restricted stock will vest on January 26, 2027. Read SEC document |
| January 21, 2026 Filed Jan 21, 2026 21:30 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | SaleCommon Stock | 13,500 | $5.23 | $70,573.95 |
DisclosureSEC source: 0001493152-26-003094 · ownership.xml · nonDerivative · entry 1 Alvino Mark · CIK 0001356828 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,752 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.21 to $5.235 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| November 13, 2025 Filed Nov 14, 2025 21:30 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | SaleCommon Stock | 15,000 | $4.74 | $71,167.50 |
DisclosureSEC source: 0001493152-25-023532 · ownership.xml · nonDerivative · entry 1 Alvino Mark · CIK 0001356828 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,252 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.68 to $4.885 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| July 09, 2025 Filed Jul 10, 2025 20:30 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | SaleCommon Stock | 13,093 | $5.86 | $76,668.68 |
DisclosureSEC source: 0001641172-25-018599 · ownership.xml · nonDerivative · entry 1 Alvino Mark · CIK 0001356828 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,252 F1 · kind: The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.78 to $5.92 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| May 27, 2025 Filed May 27, 2025 23:57 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | SaleCommon Stock | 2,000 | $6.38 | $12,760.00 |
DisclosureSEC source: 0001641172-25-012556 · ownership.xml · nonDerivative · entry 1 Alvino Mark · CIK 0001356828 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,435 Read SEC document |
| May 16, 2025 Filed May 16, 2025 21:23 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | SaleCommon Stock | 8,000 | $5.68 | $45,440.00 |
DisclosureSEC source: 0001641172-25-011289 · ownership.xml · nonDerivative · entry 1 Alvino Mark · CIK 0001356828 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,435 F1 · price: Weighted average price. These shares were sold in multiple transactions at prices ranging from $5.63 to $5.77 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 01:37 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | GrantCommon Stock | 36,101 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-004749 · ownership.xml · nonDerivative · entry 1 Alvino Mark · CIK 0001356828 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,435 F1 · kind: Upon vesting, a portion of the restricted stock may be surrendered to satisfy the reporting person's tax withholding obligation. Any deemed disposition of the withheld shares would be exempt pursuant to Rule 16b-3(e). F2 · shares: All of the restricted stock will vest on January 31, 2026. Read SEC document |
| January 29, 2025 Filed Jan 31, 2025 21:30 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | SaleCommon Stock | 4,000 | $5.38 | $21,520.00 |
DisclosureSEC source: 0001493152-25-004437 · ownership.xml · nonDerivative · entry 1 Alvino Mark · CIK 0001356828 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,334 F1 · price: Weighted average price. These shares were sold in multiple transactions at prices ranging from $5.35 to $5.41 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| January 21, 2025 Filed Jan 21, 2025 21:30 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | SaleCommon Stock | 4,000 | $5.10 | $20,400.00 |
DisclosureSEC source: 0001493152-25-003052 · ownership.xml · nonDerivative · entry 1 Alvino Mark · CIK 0001356828 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,334 F1 · price: Weighted average price. These shares were sold in multiple transactions at prices ranging from $5.08 to $5.12 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| August 26, 2024 Filed Aug 27, 2024 23:06 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | GrantCommon Stock | 11,797 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-034050 · ownership.xml · nonDerivative · entry 1 Alvino Mark · CIK 0001356828 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,334 F1 · kind: The acquisition was exempt pursuant to Rule 16b-3(d). F2 · shares: This stock grant represents the remainder of the 2024 annual grant to board of directors. This portion of the annual stock grant was withheld until all employees/management were allocated their shares and in order to enable onboarding of two new Board members. All of the restricted stock will vest on August 26, 2025. Read SEC document |
| July 08, 2024 Filed Jul 9, 2024 20:35 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | GrantCommon Stock | 23,611 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-026644 · ownership.xml · nonDerivative · entry 1 Alvino Mark · CIK 0001356828 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,537 F1 · shares: All of the restricted stock will vest on July 8, 2025. Read SEC document |
| June 18, 2024 Filed Jun 20, 2024 20:30 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | SaleCommon Stock | 25,890 | $4.51 | $116,763.90 |
DisclosureSEC source: 0001493152-24-024528 · ownership.xml · nonDerivative · entry 1 Alvino Mark · CIK 0001356828 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,926 F1 · kind: The sale reported in this Form 4 was to cover tax obligations associated with vesting of restricted stock awards. F2 · price: Weighted average price. These shares were sold in multiple transactions at prices ranging from $4.47 to $4.55 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| January 17, 2024 Filed Jan 22, 2024 21:30 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | SaleCommon Stock | 7,084 | $5.11 | $36,199.24 |
DisclosureSEC source: 0001493152-24-003193 · ownership.xml · nonDerivative · entry 1 Alvino Mark · CIK 0001356828 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,816 F1 · price: Weighted average price. These shares were sold in multiple transactions at prices ranging from $5.10 to $5.15 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| September 27, 2023 Filed Sep 29, 2023 20:30 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | SaleCommon Stock | 6,316 | $3.91 | $24,723.98 |
DisclosureSEC source: 0001493152-23-034856 · ownership.xml · nonDerivative · entry 1 Alvino Mark · CIK 0001356828 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,900 F1 · kind: The sale reported in this Form 4 was to cover tax obligations associated with vesting of restricted stock awards. F2 · price: Weighted average price. These shares were sold in multiple transactions at prices ranging from $3.8200 to $4.2050 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 20:05 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | GrantCommon Stock | 58,689 | $4.62 | $271,143.18 |
DisclosureSEC source: 0001493152-23-021652 · ownership.xml · nonDerivative · entry 1 Alvino Mark · CIK 0001356828 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,216 F1 · shares: All of the restricted stock will vest on June 14, 2024. Read SEC document |
| April 25, 2023 Filed May 5, 2023 20:05 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | SaleCommon Stock | 887 | $3.25 | $2,882.75 |
DisclosureSEC source: 0001493152-23-015587 · ownership.xml · nonDerivative · entry 1 Alvino Mark · CIK 0001356828 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,527 Read SEC document |
| September 26, 2022 Filed Sep 28, 2022 20:33 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | GrantCommon Stock | 13,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-22-027042 · ownership.xml · nonDerivative · entry 1 Alvino Mark · CIK 0001356828 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,414 F1 · shares: All of the restricted stock will vest on September 26, 2023. F2 · balance_after: On July 1, 2022, the issuer effectuated a 1-for-25 reverse stock split. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 20:17 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | SaleCommon Stock | 20,000 | $0.15 | $3,098.00 |
DisclosureSEC source: 0001493152-22-017168 · ownership.xml · nonDerivative · entry 1 Alvino Mark · CIK 0001356828 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,181 F1 · price: Reflects the average weighted price of sales on June 15, 2022. The shares were sold in multiple transactions at prices ranging from $0.152 to $0.157, inclusive. The reporting person undertakes to provide Abeona Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| June 06, 2022 Filed Jun 7, 2022 20:05 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | SaleCommon Stock | 35,000 | $0.16 | $5,463.50 |
DisclosureSEC source: 0001493152-22-016079 · ownership.xml · nonDerivative · entry 1 Alvino Mark · CIK 0001356828 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,181 F1 · price: Reflects the average weighted price of sales on June 6, 2022. The shares were sold in multiple transactions at prices ranging from $0.155 to $0.1617, inclusive. The reporting person undertakes to provide Abeona Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| May 25, 2021 Filed May 28, 2021 01:44 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | GrantStock Option (right to buy) · Derivative | 98,168 | $0.00 Strike: $1.49 | $0.00 |
DisclosureSEC source: 0001493152-21-013118 · ownership.xml · derivative · entry 2 Alvino Mark · CIK 0001356828 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,168 Underlying: Common Stock · 98,168 shares Expires 2031-05-25 F2 · derivative.exercise_date: All of the stock options will vest on November 25, 2021. Read SEC document |
| May 25, 2021 Filed May 28, 2021 01:44 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | GrantCommon Stock | 77,181 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-21-013118 · ownership.xml · nonDerivative · entry 1 Alvino Mark · CIK 0001356828 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,181 F1 · shares: All of the restricted stock will vest on November 25, 2021. Read SEC document |
| May 21, 2019 Filed May 24, 2019 00:34 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | GrantStock Option (right to buy) · Derivative | 19,827 | $0.00 Strike: $7.42 | $0.00 |
DisclosureSEC source: 0001144204-19-028043 · tv522351_4.xml · derivative · entry 1 Alvino Mark · CIK 0001356828 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,827 Underlying: Common stock · 19,827 shares Expires 2029-05-21 Read SEC document |
| December 14, 2017 Filed Dec 18, 2017 22:14 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | GrantStock option (right to buy) · Derivative | 30,000 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000318306-17-000005 · primary_doc.xml · derivative · entry 1 Alvino Mark · CIK 0001356828 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common stock · 30,000 shares Expires 2027-12-14 F1 · shares: 100% accelerated vesting on change of control. Read SEC document |
| December 13, 2016 Filed Dec 16, 2016 01:07 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | GrantStock option (right to buy) · Derivative | 50,000 | $0.00 Strike: $4.45 | $0.00 |
DisclosureSEC source: 0000318306-16-000053 · primary_doc.xml · derivative · entry 1 Alvino Mark · CIK 0001356828 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common stock · 50,000 shares Expires 2026-12-13 F1 · shares: 100% accelerated vesting on change of control. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.